Detection of aberrant signaling pathways in CD34+cells from patients with myelofibrosis with myeloid metaplasia using oligonulceotide microarrays.

被引：0
作者：
Jones, LC
Tefferi, A
Wachsman, W
Hofmann, WK
Koeffler, HP
机构：
[1] Univ Calif Los Angeles, Sch Med, Div Hematol Oncol, Cedars Sinai Res Inst, Los Angeles, CA 90024 USA
[2] Mayo Clin & Mayo Fdn, Div Hematol & Internal Med, Rochester, MN 55905 USA
[3] VASDHS, Res Serv, La Jolla, CA USA
[4] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA
来源：
BLOOD | 2001年 / 98卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2620
引用
收藏
页码：626A / 626A
页数：1
相关论文
共 50 条
[31]   Generation of Myeloid Cells from Cord Blood-Derived CD34+Cells for Therapeutic Intent [J].
Kreuser, Shannon ;
Davis, Nicholas ;
Stoltzman, Carrie ;
von Euw, Erika ;
Delaney, Colleen .
STEM CELLS TRANSLATIONAL MEDICINE, 2022, 11 (SUPPL 1) :S5-S5
[32]   Myeloablative therapy with i.v.Treosulfan and autologous peripheral blood progenitor cell transplantation (PBPCT) with high doses of CD34+cells results in hematologic responses in patients with myelofibrosis with myeloid metaplasia. [J].
Fruehauf, S ;
Buss, EC ;
Villalobos, M ;
Topaly, J ;
Kreipe, HH ;
Ho, AD .
BLOOD, 2002, 100 (11) :348B-348B
[33]   Reduced expression of CXCR4 on circulating CD34+ cells is associated with hematopoietic progenitor cells (HPC) mobilization in patients with myelofibrosis with myeloid metaplasia (MMM). [J].
Massa, M ;
Rosti, V ;
Vannuccchi, AM ;
Campanelli, R ;
Pecci, A ;
Viarengo, G ;
Meli, V ;
Marchetti, M ;
Guglielmelli, P ;
Bruno, E ;
Xu, M ;
Hoffman, R ;
Barosi, G .
BLOOD, 2005, 106 (11) :79A-79A
[34]   Differential antigen expression and aberrant signaling via PI3/AKT, MAP/ERK, JAK/STAT, and Wnt/β catenin pathways in Lin-/CD38-/CD34+cells in acute myeloid leukemia [J].
Garg, Swati ;
Shanmukhaiah, Chandrakala ;
Marathe, Supreet ;
Mishra, Prashant ;
Rao, Vunditi Babu ;
Ghosh, Kanjaksha ;
Madkaikar, Manisha .
EUROPEAN JOURNAL OF HAEMATOLOGY, 2016, 96 (03) :309-317
[35]   Proteins Marking the Sequence of Genotoxic Signaling from Irradiated Mesenchymal Stromal Cells to CD34+Cells [J].
Kohl, Vanessa ;
Drews, Oliver ;
Costina, Victor ;
Bierbaum, Miriam ;
Jawhar, Ahmed ;
Roehl, Henning ;
Weiss, Christel ;
Brendel, Susanne ;
Kleiner, Helga ;
Flach, Johanna ;
Spiess, Birgit ;
Seifarth, Wolfgang ;
Nowak, Daniel ;
Hofmann, Wolf-Karsten ;
Fabarius, Alice ;
Popp, Henning D. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
[36]   Does cytogenetic mosaicism in CD34+CD38low cells reflect the persistence of normal primitive hematopoietic progenitors in myeloid metaplasia with myelofibrosis? [J].
Bilhou-Nabéra, C ;
Brigaudeau, C ;
Clay, D ;
Andrieux, J ;
Lai, JL ;
Brouty-Boyé, D ;
Vignon, C ;
Gharbi, MJ ;
Le Bousse-Kerdilès, MC ;
Praloran, V .
BLOOD, 2003, 102 (04) :1551-1552
[37]   High circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK 2 mutation differentiate secondary myelofibrosis associated with pulmonary hypertension from myelofibrosis with myeloid metaplasia. [J].
Popat, U ;
Liu, E ;
Guan, Y ;
Prchal, JT .
BLOOD, 2005, 106 (11) :728A-728A
[38]   In vitro effects of imatinib on CD34+cells of patients with chronic myeloid leukemia in the megakaryocytic crisis phase [J].
Meng, Fankai ;
Zeng, Wen ;
Huang, Lifang ;
Qin, Shuang ;
Miao, Ningning ;
Sun, Hanying ;
Li, Chunrui .
ONCOLOGY LETTERS, 2014, 7 (03) :791-796
[39]   Functional maturation of myeloid cells during in vitro differentiation from human cord blood CD34+cells [J].
Jung, YJ ;
Woo, SY ;
Ryu, KH ;
Chung, WS ;
Kie, JH ;
Seoh, JY .
HAEMATOLOGICA, 2002, 87 (11) :1222-1223
[40]   Characterization of Splenic CD34+ Cells From Patients with Primary Myelofibrosis [J].
Wang, Xiaoli ;
Prakash, Sonam ;
Lu, Min ;
Li, Yan ;
Orazi, Attilio ;
Hoffman, Ronald .
BLOOD, 2011, 118 (21) :1211-1212
12345